Stock Markets June 17, 2026 06:06 AM

Carter’s Shares Rise After Wells Fargo Upgrades Stock, Raises Target to $42

Analyst cites leadership change, direct-to-consumer momentum and tariff tailwinds as drivers behind the upgrade

By Sofia Navarro
Share
Twitter Reddit Facebook LinkedIn
CRI

Carter’s (CRI) stock climbed in premarket trading after Wells Fargo analyst Ike Boruchow upgraded the shares from Underweight to Equal Weight and lifted the price target to $42 from $30. The analyst pointed to improvements under a new CEO, continued direct-to-consumer growth and possible benefits from lower tariffs. Wells Fargo also raised near-term sales and multi-year earnings estimates and called the upcoming second-quarter report a likely positive catalyst.

Carter’s Shares Rise After Wells Fargo Upgrades Stock, Raises Target to $42
CRI
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Wells Fargo upgraded Carters from Underweight to Equal Weight and raised the price target to $42 from $30.
  • Analyst Ike Boruchow cited improved leadership under a new CEO, sustained direct-to-consumer growth, and potential upside from lower tariff rates as reasons for the upgrade.
  • Wells Fargo raised its Q2 comparable sales estimate and increased fiscal 2026 and 2027 EPS estimates to $3.30 and $3.80, respectively, both above consensus; the $42 target equals 11 times the firm's 2027 EPS estimate.

Carter’s (NYSE: CRI) shares climbed 3.5% in premarket trading on Monday following a ratings change from Wells Fargo. Analyst Ike Boruchow moved the stock from Underweight to Equal Weight and raised the firms price objective to $42 from $30.

In a note accompanying the upgrade, Boruchow pointed to three central developments that influenced the revision: management changes under a new chief executive officer, ongoing strength in direct-to-consumer (DTC) sales and the prospect of reduced tariff costs.

He summarized his view of the companys trajectory in direct language:

"The combo of new leadership + evolved DTC strategies is driving fundamental improvements in the model in our view. At the same time, we believe CRI has some very under-appreciated inorganic upside via lower tariff rates,"
keeping the emphasis on both operational execution and potential margin benefits from cheaper import costs.

Wells Fargo adjusted its near-term sales outlook for Carters, raising its estimate for second-quarter comparable sales. The firm said it expects the forthcoming second-quarter earnings release to act as a positive catalyst for the shares, adding that third-quarter guidance and margin metrics are likely to beat consensus expectations.

On the earnings front, the bank increased its fiscal 2026 earnings-per-share (EPS) projection to $3.30 from $3.00 and pushed fiscal 2027 EPS to $3.80 from $3.50. Both revised figures sit above the consensus estimates noted by the analyst, which are $3.22 for fiscal 2026 and $3.61 for fiscal 2027.

The new $42 price target corresponds to a multiple of 11 times Wells Fargos 2027 EPS estimate.


Market and sector context

  • The company is a participant in the childrens apparel segment of the consumer discretionary sector, and its shares responded positively to the analysts reassessment.
  • Tariff developments noted by the analyst tie the companys margins to trade policy and import cost dynamics, a consideration for apparel and retail supply chains.

What to watch next

  • The firm flagged the upcoming second-quarter earnings report as a likely catalyst, and investors will be watching reported comparable sales and management commentary for confirmation of the analysts expectations.

Risks

  • Tariff outcomes remain uncertain - the analyst noted potential benefits from lower tariff rates, implying that unchanged or higher tariffs could limit the expected margin improvement (impacts apparel and retail supply chains).
  • The anticipated positive impact from upcoming quarterly results and guidance is not guaranteed - Wells Fargo expects the second-quarter report to be a catalyst and that third-quarter guidance and margins will likely exceed expectations, but these remain projections tied to company performance (impacts investors and the retail sector).

More from Stock Markets

Palladyne AI Shares Climb After Winning U.S. Army Development and Validation Contracts Jun 17, 2026 Monolithic Power Systems Inches Higher Pre-Market as AI Infrastructure Outlook Strengthens Jun 17, 2026 Broadcom Gains Pre-Market After Wolfe Research Expands Long-Term AI Revenue Forecast Jun 17, 2026 ClearPoint Neuro Shares Leap After UniQure-FDA Discussion on AMT-130 Data Jun 17, 2026 uniQure Shares Eye Gains After FDA Agrees 3-Year AMT-130 Data Can Anchor BLA for Accelerated Approval Jun 17, 2026